Assyro AI

Orange Book product · Generic (ANDA)

DULOXETINE HYDROCHLORIDE

DULOXETINE HYDROCHLORIDE

Generic (ANDA)ANDA 208706TE ABRX AJANTA PHARMA LTD

At a glance

Jan 06, 2017

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 06, 2017

    9 yr 7 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

DULOXETINE HYDROCHLORIDE

Strength

EQ 60MG BASE

Dosage form

CAPSULE, DELAYED REL PELLETS

Route

ORAL

TE code

AB

Application

ANDA 208706

Product number

003

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

Yes

Active-ingredient family

View full family

Generic (ANDA) of DULOXETINE HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.